
Inspire Medical Systems INSP
$ 50.13
-0.63%
Annual report 2025
added 02-13-2026
Inspire Medical Systems Interest Expense 2011-2026 | INSP
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Inspire Medical Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.66 M | -855 K | -195 K | -49 K | 2.13 M | 2.12 M | 2.12 M | 3.3 M | 1.75 M | 1.3 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.3 M | -2.66 M | 897 K |
Quarterly Interest Expense Inspire Medical Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -66 K | -3.5 M | 578 K | - | 118 K | -135 K | -60 K | - | -224 K | -61 K | 17 K | - | 656 K | 494 K | 527 K | - | 537 K | 530 K | 523 K | - | 533 K | 526 K | 525 K | - | 529 K | 523 K | 537 K | - | 680 K | 550 K | 1.38 M | - | 428 K | 4 K | -1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.38 M | -3.5 M | 228 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Xtant Medical Holdings
XTNT
|
4.16 M | $ 0.55 | -2.31 % | $ 73.5 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Zimmer Biomet Holdings
ZBH
|
-31.1 M | $ 88.57 | -0.65 % | $ 18 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 10.93 | -5.12 % | $ 1.64 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Accuray Incorporated
ARAY
|
559 K | $ 0.4 | 4.21 % | $ 41.1 M | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 208.22 | -4.53 % | $ 14.6 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 34.58 | -5.62 % | $ 1.07 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.15 | -5.29 % | $ 3.36 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 79.34 | -3.36 % | $ 46.4 B | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.2 | -1.84 % | $ 1.51 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.52 | -5.08 % | $ 364 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
99 K | - | 10.0 % | $ 610 K | ||
|
Myomo
MYO
|
-668 K | $ 0.7 | 2.32 % | $ 29.3 M | ||
|
Penumbra
PEN
|
893 K | $ 335.1 | -0.39 % | $ 13 B | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.17 | -5.65 % | $ 47.6 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
-421 K | - | - | $ 217 M | ||
|
Surgalign Holdings
SRGA
|
1.01 M | - | -32.98 % | $ 1.68 M | ||
|
STRATA Skin Sciences
SSKN
|
926 K | - | - | $ 6.6 M | ||
|
AVITA Medical
RCEL
|
5 M | $ 3.82 | -1.04 % | $ 106 M | ||
|
AxoGen
AXGN
|
167 K | $ 31.28 | -3.01 % | $ 1.44 B |